| Sri Kiran Chennupati, MD | |
|
1210 S Cedar Crest Blvd, Suite 1100, Allentown, PA 18103-6229 | |
| (610) 402-7999 | |
| (610) 402-7995 |
| Full Name | Sri Kiran Chennupati |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 20 Years |
| Location | 1210 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891851812 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Nyon, Switzerland A study from the University of Southampton and Sheffield Medical School in the UK projects a dramatic increase in the burden of fragility fractures within the next three decades.
Researchers have discovered how a common mutation in a high-risk leukemia subtype drives the cancer's aggressiveness and have identified drugs that may work with existing precision medicines to improve survival. St. Jude Children's Research Hospital scientists led the study, which was published online today in the journal Cancer Cell.
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.
Sound Physicians, a leading hospitalist organization focused on measurably improving the quality, satisfaction, efficiency and financial performance of healthcare delivery, today announced the availability of its Value-Based Purchasing Performance Assessment Tool to all hospitals at no cost.
› Verified 9 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Nyon, Switzerland A study from the University of Southampton and Sheffield Medical School in the UK projects a dramatic increase in the burden of fragility fractures within the next three decades.
Researchers have discovered how a common mutation in a high-risk leukemia subtype drives the cancer's aggressiveness and have identified drugs that may work with existing precision medicines to improve survival. St. Jude Children's Research Hospital scientists led the study, which was published online today in the journal Cancer Cell.
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.
Sound Physicians, a leading hospitalist organization focused on measurably improving the quality, satisfaction, efficiency and financial performance of healthcare delivery, today announced the availability of its Value-Based Purchasing Performance Assessment Tool to all hospitals at no cost.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sri Kiran Chennupati, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Sri Kiran Chennupati, MD 1210 S Cedar Crest Blvd, Suite 1100, Allentown, PA 18103-6229 Ph: (610) 402-7999 |
News Archive
Nyon, Switzerland A study from the University of Southampton and Sheffield Medical School in the UK projects a dramatic increase in the burden of fragility fractures within the next three decades.
Researchers have discovered how a common mutation in a high-risk leukemia subtype drives the cancer's aggressiveness and have identified drugs that may work with existing precision medicines to improve survival. St. Jude Children's Research Hospital scientists led the study, which was published online today in the journal Cancer Cell.
It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.
Sound Physicians, a leading hospitalist organization focused on measurably improving the quality, satisfaction, efficiency and financial performance of healthcare delivery, today announced the availability of its Value-Based Purchasing Performance Assessment Tool to all hospitals at no cost.
› Verified 9 days ago
Robert Dedio, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 | |
Dr. Robert D Strauss, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4734 Lynnfield Ln, South Gate, Allentown, PA 18104 Phone: 610-391-1810 | |
Hilary Koprowski Ii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 Fax: 610-366-7412 | |
Niketu Patel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 Fax: 610-366-7412 | |
Paul Stuart Lemberg, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd, Ste 203, Allentown, PA 18104 Phone: 610-366-1366 Fax: 610-366-7412 | |
John S Papola, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 250 Sylvia Ln, Allentown, PA 18104 Phone: 610-481-0895 | |
Dr. Karen Shemanski, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1575 Pond Rd Ste 203, Allentown, PA 18104 Phone: 610-366-1366 |